Exploring the Relationship Between Stimulant Use and Serious Mental Illness-Presentation Slides

Presentation Slides

Pdf Summary

This document is a presentation from an APA and SAMHSA initiative exploring the relationship between stimulant use and serious mental illness. It provides information on the clinical support system for serious mental illness (CSS-SMI), faculty members involved in the initiative, and disclosures of conflicts of interest. The learning objectives of the presentation include distinguishing different forms of stimulants, recognizing unique characteristics of stimulant-induced psychosis versus schizophrenia, characterizing emerging potent forms of methamphetamine, and identifying evidence-based treatments for stimulant use disorders.<br /><br />The document discusses the criteria for diagnosing stimulant use disorder according to the DSM-5, as well as the symptoms of stimulant intoxication and withdrawal. It also compares and contrasts stimulant-induced psychosis with schizophrenia in terms of psychiatric and behavioral effects.<br /><br />The document provides an overview of cocaine, its use methods, and its physiological effects, including its impact on cognitive function. It also mentions the increasing use of methamphetamine in the U.S. and the impact it has on individuals experiencing homelessness. The different forms of cocaine and their characteristics are discussed, as well as the potential risks associated with cocaine use, such as cocaethylene toxicity and levamisole-induced neutropenia.<br /><br />The presentation also covers the pharmacotherapy options for cocaine use disorder and emphasizes the importance of behavioral therapies in treating stimulant use disorders, such as the Matrix Model and contingency management. It highlights the high drop-out rate among cocaine users and the effectiveness of behavioral therapies in reducing substance use.<br /><br />In terms of methamphetamine use, the document discusses the increasing prevalence of methamphetamine use and overdose deaths in recent years. It highlights the different methods of obtaining stimulants and the range of physiological and behavioral effects associated with their use. The presentation also explores the distinction between methamphetamine-associated psychosis and primary psychosis, as well as the risk factors for chronic methamphetamine psychosis.<br /><br />The document concludes with information about the medication management and behavioral therapies for treating stimulant use disorders, including the use of antipsychotics, extended naltrexone, bupropion, and contingency management approaches. It also mentions the community reinforcement approach and harm reduction strategies as part of the treatment continuum.

Keywords

stimulant use

serious mental illness

stimulant-induced psychosis

schizophrenia

methamphetamine

evidence-based treatments

cocaine use disorder

behavioral therapies

methamphetamine use

medication management